FDA-Drug2026-03-11Class I
SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
ANTHONY TRINH, 123Herbals LLC
Hazard
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
Sold states
USA nationwide
Affected count
N/A
Manufactured in
7214 Berne St, N/A, Rosemead, CA, United States
Products
SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0388-2026Original summary
SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam. All lots within expiry Distribution: USA nationwide Affected quantity: N/A
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief